Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T DOLLERY

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
Clinical Science (London, England : 1979)|December 1, 1980
Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertensionJ Webster, C T Dollery, C N Hensby
Hypertension (Dallas, Tex. : 1979)|January 1, 1981
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertensionV Hossmann, G A FitzGerald, C T Dollery
Lancet (London, England)|September 10, 1977
Minoxidil in resistant hypertensionH J Dargie, C T Dollery, J Daniel
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1978
Site of action of methyldopa in lowering the blood pressure in manF Kersting, J L Reid, C T Dollery
Clinical and Experimental Hypertension|January 1, 1980
Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacinI Miyamori, M J Brown, C T Dollery
Clinical Pharmacology and Therapeutics|August 1, 1981
Norepinephrine release in essential hypertensionG A FitzGerald, V Hossmann, C T Dollery
British Heart Journal|February 1, 1976
Change in symptoms of hypertensive patients after referral to hospital clinicC J Bulpitt, C T Dollery, S Carne
British Journal of Clinical Pharmacology|August 1, 1976
Labetalol in resistant hypertensionH J Dargie, C T Dollery, J Daniel
Clinical Pharmacology and Therapeutics|February 1, 1981
Regulation of norepinephrine release by peripheral alpha 2-receptor stimulationG A FitzGerald, J Watkins, C T Dollery
Clinical Pharmacology and Therapeutics|May 1, 1977
Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitorsF Kersting, J L Reid, C T Dollery
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
Clinical Science (London, England : 1979)|December 1, 1980
Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertensionJ Webster, C T Dollery, C N Hensby
Hypertension (Dallas, Tex. : 1979)|January 1, 1981
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertensionV Hossmann, G A FitzGerald, C T Dollery
Lancet (London, England)|September 10, 1977
Minoxidil in resistant hypertensionH J Dargie, C T Dollery, J Daniel
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1978
Site of action of methyldopa in lowering the blood pressure in manF Kersting, J L Reid, C T Dollery
Clinical and Experimental Hypertension|January 1, 1980
Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacinI Miyamori, M J Brown, C T Dollery
Clinical Pharmacology and Therapeutics|August 1, 1981
Norepinephrine release in essential hypertensionG A FitzGerald, V Hossmann, C T Dollery
British Heart Journal|February 1, 1976
Change in symptoms of hypertensive patients after referral to hospital clinicC J Bulpitt, C T Dollery, S Carne
British Journal of Clinical Pharmacology|August 1, 1976
Labetalol in resistant hypertensionH J Dargie, C T Dollery, J Daniel
Clinical Pharmacology and Therapeutics|February 1, 1981
Regulation of norepinephrine release by peripheral alpha 2-receptor stimulationG A FitzGerald, J Watkins, C T Dollery
Clinical Pharmacology and Therapeutics|May 1, 1977
Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitorsF Kersting, J L Reid, C T Dollery
Pageof 22